US begins testing a universal flu vaccine

Pfizer to begin testing universal coronavirus vaccines

Creating a vaccine that works against a variety of coronaviruses, including COVID-19, represents a holy grail.

US begins testing a universal flu vaccine

Story at a glance Flu vaccine efficacy varies from year to year due to a host of factors. In an effort to better protect against influenza, researchers developed a whole-virus vaccine. Previous tri…

BioNTech and Pfizer to Begin Testing Universal Coronavirus Vaccine

BioNTech announced it is partnering with Pfizer to begin testing a next-generation universal vaccine against coronaviruses, including SARS-CoV-2, the coronavirus that causes COVID-19.

The universal flu vaccine is a reality and has been developed by the U.S. UU.

The phase 1 trial will recruit up to 100 healthy subjects randomly distributed into three groups: intranasal, intramuscular, or placebo. In mice they were a success.

BioNTech and Pfizer to Start Testing Universal Coronavirus Vaccine

They are studying injections that improve T cells and that further protect against possible serious diseases triggered by SARS-CoV-2.